Early Stage
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Prospective Observational Study on Efficacy of TARE for Early Stage HCC (NCT07278102) | Seoul National University Hospital | 2022-03-28 |
| A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102) (NCT05254899) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-11-10 |
| Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL (NCT05149170) | Chinese Academy of Medical Sciences | 2021-10-01 |
| Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma (NCT03936452) | Sun Yat-sen University | 2019-04-28 |
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer (NCT03794544) | MedImmune LLC | 2019-03-08 |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer (NCT02750358) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
Track Early Stage automatically
Every clearance here is in the API, with alerts when new ones post.